Skip to main content

Together we are beating cancer

Donate now

Search Results: TRACERx

Showing 12 out of 79 results

In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples.  In one of their recently published papers, TRACERx researchers may have found a new way to track changes in a tumour and see how likely it is to spread, by looking at blood samples. 

by Amy Warnock | Analysis | 1 May 2023

1 May 2023

Non small cell lung cancer cells stained in pleural effusion sample.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment. Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

by Jacob Smith | Analysis | 12 April 2023

12 April 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx. This episode features our Chief Clinician Professor Charles Swanton. He talks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.

by Phil Prime | Podcast | 1 November 2022

1 November 2022

This entry is part 7 of 9 in the series Cancer Research Matters - series 1
Artist visualisation of cells clustered

In the first of a new blog series on the power of philanthropy, we look at TRACERx – the first longitudinal, large-scale study of lung cancer evolution. In the first of a new blog series on the power of philanthropy, we look at TRACERx – the first longitudinal, large-scale study of lung cancer evolution.

by Cancer Research UK | Philanthropy and partnerships | 4 June 2020

4 June 2020

  • Science & Technology
  • Health & Medicine

Two years on for our pioneering TRACERx lung cancer study

Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part. Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part.

by Henry Scowcroft | Analysis | 2 September 2015

2 September 2015

TRACERx-logo

We've announced a huge research project called TRACERx, investing millions of pounds into understanding the genetic driving force behind lung cancer. We've announced a huge research project called TRACERx, investing millions of pounds into understanding the genetic driving force behind lung cancer.

by Henry Scowcroft | Analysis | 18 July 2013

18 July 2013

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

by Phil Prime | In depth | 10 March 2023

10 March 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023